Solid oral dosage form medications identified by one or two of the three pharmacists to be inappropriate for modification
| Medications | Reasons |
| Identified by any two of three pharmacists | |
| Entecavir 0.5 mg tablet | Hazardous product |
| Isosorbide mononitrate 60 mg CR tablet | Modified-release product |
| Phenytoin 100 mg capsule | Hazardous product Extended-release formulation |
| Identified by any one of three pharmacists | |
| Amoxicillin/ clavulanic acid 625 mg capsule | Hazardous product |
| Doxycycline 100 mg capsule | Hazardous product |
| Fenofibrate 100 mg capsule | Pharmacist’s knowledge that crushing is not recommended as per manufacturer’s leaflet |
| Iron polymaltose 100 mg tablet | Pharmacist’s knowledge that drops are recommended alternatives by manufacturer when crushing is needed |
| Levetiracetam 250 mg tablet | Objectional taste (patient on oral administration) |
| Levodopa/ benserazide 125 mg capsule | Pharmacist’s knowledge that crushing is not recommended as per manufacturer’s leaflet |
| Omega-3 fish oil capsule | Objectional taste/smell |
| Vitamin B1 100 mg, B6 200 mg, B12 200 μg tablet | Pharmacist’s knowledge that crushing is not recommended as per manufacturer’s leaflet |